{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T04:27:49Z","timestamp":1779337669765,"version":"3.51.4"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T00:00:00Z","timestamp":1705536000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T00:00:00Z","timestamp":1705536000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1007\/s00702-023-02718-2","type":"journal-article","created":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T17:02:52Z","timestamp":1705597372000},"page":"213-228","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Oxidation of dopamine and related catechols in dopaminergic brain regions in Parkinson\u2019s disease and during ageing in non-Parkinsonian subjects"],"prefix":"10.1007","volume":"131","author":[{"given":"Bodil","family":"Fornstedt Wallin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,18]]},"reference":[{"key":"2718_CR1","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1001\/archneur.1975.00490440064010","volume":"32","author":"LM Ambani","year":"1975","unstructured":"Ambani LM, Melvin H, Van Woert MH, Murphy S (1975) Brain peroxidase and catalase in Parkinson disease. Arch Neurol 32:114\u2013118","journal-title":"Arch Neurol"},{"key":"2718_CR2","first-page":"360","volume":"138","author":"AH Anton","year":"1962","unstructured":"Anton AH, Sayre DF (1962) A study of the factors affecting the aluminum oxide trihydroxyindole procedure for the analysis of catecholamines. J Pharmacol Exp Ther 138:360\u2013375","journal-title":"J Pharmacol Exp Ther"},{"key":"2718_CR3","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/ng1769","volume":"38","author":"A Bender","year":"2006","unstructured":"Bender A, Krishnan KJ, Morris CM, Taylor GA, Reeve AK, Perry RH, Jaros E, Hersheson JS, Betts J, Klopstock T, Taylor RW, Turnbull DM (2006) High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nat Genet 38:515\u2013517","journal-title":"Nat Genet"},{"issue":"5","key":"2718_CR4","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1111\/j.1471-4159.1991.tb06358.x","volume":"57","author":"D Ben-Shachar","year":"1991","unstructured":"Ben-Shachar D, Riederer P, Youdim MBH (1991) Iron\u2013melanin interaction and lipid peroxidation: implications for Parkinson\u2019s disease. J Neurochem 57(5):1609\u20131614. https:\/\/doi.org\/10.1111\/j.1471-4159.1991.tb06358.x","journal-title":"J Neurochem"},{"issue":"4","key":"2718_CR5","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/0022-510x(73)90175-5","volume":"20","author":"H Bernheimer","year":"1973","unstructured":"Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F (1973) Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci 20(4):415\u2013455. https:\/\/doi.org\/10.1016\/0022-510x(73)90175-5","journal-title":"J Neurol Sci"},{"issue":"21","key":"2718_CR6","doi-asserted-by":"publisher","first-page":"15597","DOI":"10.1074\/jbc.M610893200","volume":"282","author":"M Bisaglia","year":"2007","unstructured":"Bisaglia M, Mammi S, Bubacco L (2007) Kinetic and structural analysis of the early oxidation products of dopamine: analysis of the interactions with alpha-synuclein. J Biol Chem 282(21):15597\u201315605. https:\/\/doi.org\/10.1074\/jbc.M610893200","journal-title":"J Biol Chem"},{"issue":"s2","key":"2718_CR7","doi-asserted-by":"publisher","first-page":"S281","DOI":"10.3233\/JPD-191721","volume":"9","author":"P Borghammer","year":"2019","unstructured":"Borghammer P, Van Den Berge N (2019) Brain-first versus gut-first Parkinson\u2019s disease: a hypothesis. J Parkinson\u2019s Dis 9(s2):S281\u2013S295. https:\/\/doi.org\/10.3233\/JPD-191721","journal-title":"J Parkinson\u2019s Dis"},{"issue":"2","key":"2718_CR8","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/s0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, R\u00fcb U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24(2):197\u2013211. https:\/\/doi.org\/10.1016\/s0197-4580(02)00065-9","journal-title":"Neurobiol Aging"},{"issue":"6357","key":"2718_CR9","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1126\/science.aam9080","volume":"357","author":"LF Burbulla","year":"2017","unstructured":"Burbulla LF, Song P, Mazzulli JR, Zampese E, Wong YC, Jeon S, Santos DP, Blanz J, Obermaier CD, Strojny C, Savas JN, Kiskinis E, Zhuang X, Kr\u00fcger R, Surmeier DJ, Kranic D (2017) Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson\u2019s disease. Science 357(6357):1255\u20131261. https:\/\/doi.org\/10.1126\/science.aam9080","journal-title":"Science"},{"key":"2718_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2023.102414","volume":"223","author":"W Cai","year":"2023","unstructured":"Cai W, Wakamatsu K, Zucca FA, Wang Q, Yang K, Mohamadzadehonarvar N, Srivastava P, Tanaka H, Holly G, Casella L, Ito S, Zecca L, Chen X (2023) DOPA pheomelanin is increased in nigral neuromelanin of Parkinson\u2019s disease. Prog Neurobiol 223:102414. https:\/\/doi.org\/10.1016\/j.pneurobio.2023.102414","journal-title":"Prog Neurobiol"},{"key":"2718_CR11","first-page":"67","volume-title":"Funktionsst\u00f6rungen des Gehirns im Alter","author":"A Carlsson","year":"1981","unstructured":"Carlsson A (1981) Aging and brain neurotransmitters. In: Platt D (ed) Funktionsst\u00f6rungen des Gehirns im Alter. F.K. Schattauer Verlag, Stuttgart\/New York, pp 67\u201381"},{"key":"2718_CR12","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/j.1600-0404.1991.tb05014.x","volume":"136","author":"A Carlsson","year":"1991","unstructured":"Carlsson A, Fornstedt B (1991) Possible mechanisms underlying the special vulnerability of dopaminergic neurons. Acta Neurol Scand Suppl 136:16\u201318. https:\/\/doi.org\/10.1111\/j.1600-0404.1991.tb05014.x","journal-title":"Acta Neurol Scand Suppl"},{"issue":"5","key":"2718_CR13","doi-asserted-by":"publisher","first-page":"373","DOI":"10.2340\/0001555570373377","volume":"70","author":"R Carstam","year":"1990","unstructured":"Carstam R, Brinck C, Fornstedt B, Rorsman H, Rosengren E (1990) 5-S-cysteinyldopac in human urine. Acta Derm Venereol 70(5):373\u2013377 (PMID: 1980968)","journal-title":"Acta Derm Venereol"},{"key":"2718_CR14","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/0140-6736(90)91099-V","volume":"335","author":"I Ceballos","year":"1990","unstructured":"Ceballos I, Lafon M, Javoy-Agid F, Hirsch E, Sinet PM, Agid Y (1990) Superoxide dismutase and Parkinson\u2019s disease. Lancet 335:1035\u20131036","journal-title":"Lancet"},{"issue":"suppl","key":"2718_CR16","first-page":"89","volume":"19","author":"G Cohen","year":"1983","unstructured":"Cohen G (1983) The pathobiology of Parkinson\u2019s disease: Biochemical aspects of dopamine neuron senescence. J Neural Transm 19(suppl):89\u2013103","journal-title":"J Neural Transm"},{"key":"2718_CR17","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1002\/ana.410260518","volume":"26","author":"G Cohen","year":"1989","unstructured":"Cohen G, Spina MB (1989) Deprenyl supresses the oxidant stress associated with increased dopamine turnover. Ann Neurol 26:689\u2013690","journal-title":"Ann Neurol"},{"key":"2718_CR18","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/S0140-6736(86)92471-2","volume":"2","author":"D Dexter","year":"1986","unstructured":"Dexter D, Carter C, Agid F, Agid Y, Lees AJ, Jenner P, Marsden CD (1986) Lipid peroxidation as cause of nigral cell death in Parkinson\u2019s disease. Lancet 2:639\u2013640","journal-title":"Lancet"},{"key":"2718_CR19","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/S0140-6736(87)91361-4","volume":"2","author":"DT Dexter","year":"1987","unstructured":"Dexter DT, Wells FR, Agid F, Agid Y, Lees AJ, Jenner P, Mardsen CD (1987) Increased nigral iron content in postmortem parkinsonian brain. Lancet 2:1219\u20131220","journal-title":"Lancet"},{"key":"2718_CR20","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1111\/j.1471-4159.1989.tb07264.x","volume":"52","author":"DT Dexter","year":"1989","unstructured":"Dexter DT, Wells FR, Lees AJ, Agid F, Agid Y, Jenner P, Mardsen CD (1989) Increased nigral iron content and alterations in other metal ioans occurring in brain in Parkinson\u2019s disease. J Neurochem 52:1830\u20131836","journal-title":"J Neurochem"},{"key":"2718_CR21","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/j.1471-4159.1990.tb08814.x","volume":"55","author":"DT Dexter","year":"1990","unstructured":"Dexter DT, Carayon A, Vidailhet M, Ruberg M, Agid F, Agid Y, Lees AJ, Wells FR, Jenner P, Mardsen CD (1990) Decreased ferritin levels in brain in Parkinson\u2019s disease. J Neurochem 55:16\u201320","journal-title":"J Neurochem"},{"key":"2718_CR22","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1007\/BF01485901","volume":"38","author":"H Ehringer","year":"1960","unstructured":"Ehringer H, Hornykiewicz O (1960) Verteilung von noradrenalin und dopamin (3-Hydroxytyramin) im Gehirn des Menschen und ihr Verhalten bei Erktankungen des Extrapyramidalen Systems. Klin Wschr 38:1236\u20131239","journal-title":"Klin Wschr"},{"issue":"11","key":"2718_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0048490","volume":"7","author":"M Engelen","year":"2012","unstructured":"Engelen M, Vanna R, Bellei C, Zucca FA, Wakamatsu K, Monzani E, Ito S, Casella L, Zecca L (2012) Neuromelanins of human brain have soluble and insoluble components with dolichols attached to the melanic structure. PLoS One 7(11):e48490. https:\/\/doi.org\/10.1371\/journal.pone.0048490","journal-title":"PLoS One"},{"issue":"1","key":"2718_CR24","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.tins.2016.10.008","volume":"40","author":"S Engelender","year":"2017","unstructured":"Engelender S, Isacson O (2017) The threshold theory for Parkinson\u2019s disease. Trends Neurosci 40(1):4\u201314. https:\/\/doi.org\/10.1016\/j.tins.2016.10.008","journal-title":"Trends Neurosci"},{"issue":"4","key":"2718_CR25","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1111\/j.1471-4159.2005.03638.x","volume":"96","author":"M Fasano","year":"2006","unstructured":"Fasano M, Bergamsco B, Lopiano L (2006) Modifications of the iron-neuromelanin system in Parkinson\u2019s disease. J Neurochem 96(4):909\u2013916","journal-title":"J Neurochem"},{"issue":"6","key":"2718_CR26","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.neuron.2018.07.028","volume":"99","author":"G Fofani","year":"2018","unstructured":"Fofani G, Obeso JA (2018) A cortical pathogenic theory of Parkinson\u2019s disease. Neuron 99(6):1116\u20131128. https:\/\/doi.org\/10.1016\/j.neuron.2018.07.028","journal-title":"Neuron"},{"issue":"2","key":"2718_CR27","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/BF01578755","volume":"76","author":"B Fornstedt","year":"1989","unstructured":"Fornstedt B, Carlsson A (1989) A marked rise in 5-S-cysteinyl-dopamine levels in guinea-pig striatum following reserpine treatment. J Neural Transm 76(2):155\u2013161. https:\/\/doi.org\/10.1007\/BF01578755","journal-title":"J Neural Transm"},{"issue":"5","key":"2718_CR28","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/0028-3908(91)90007-x","volume":"30","author":"B Fornstedt","year":"1991","unstructured":"Fornstedt B, Carlsson A (1991a) Effects of inhibition of monoamine oxidase on the levels of 5-S-cysteinyl adducts of catechols in dopaminergic regions of the brain of the guinea pig. Neuropharmacology 30(5):463\u2013468. https:\/\/doi.org\/10.1016\/0028-3908(91)90007-x","journal-title":"Neuropharmacology"},{"issue":"2","key":"2718_CR29","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/j.1471-4159.1991.tb08166.x","volume":"56","author":"B Fornstedt","year":"1991","unstructured":"Fornstedt B, Carlsson A (1991b) Vitamin C deficiency facilitates 5-S-cysteinyldopamine formation in guinea pig striatum. J Neurochem 56(2):407\u2013414. https:\/\/doi.org\/10.1111\/j.1471-4159.1991.tb08166.x","journal-title":"J Neurochem"},{"issue":"4","key":"2718_CR30","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/0028-3908(86)90242-x","volume":"25","author":"B Fornstedt","year":"1986","unstructured":"Fornstedt B, Rosengren E, Carlsson A (1986) Occurrence and distribution of 5-S-cysteinyl derivatives of dopamine, dopa and dopac in the brains of eight mammalian species. Neuropharmacology 25(4):451\u2013454. https:\/\/doi.org\/10.1016\/0028-3908(86)90242-x","journal-title":"Neuropharmacology"},{"issue":"4","key":"2718_CR31","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/BF02263482","volume":"1","author":"B Fornstedt","year":"1989","unstructured":"Fornstedt B, Brun A, Rosengren E, Carlsson A (1989) The apparent autoxidation rate of catechols in dopamine-rich regions of human brains increases with the degree of depigmentation of substantia nigra. J Neural Transm Park Dis Dement Sect 1(4):279\u2013295. https:\/\/doi.org\/10.1007\/BF02263482","journal-title":"J Neural Transm Park Dis Dement Sect"},{"issue":"2","key":"2718_CR32","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1111\/j.1471-4159.1990.tb01910.x","volume":"54","author":"B Fornstedt","year":"1990","unstructured":"Fornstedt B, Bergh I, Rosengren E, Carlsson A (1990a) An improved HPLC-electrochemical detection method for measuring brain levels of 5-S-cysteinyldopamine, 5-S-cysteinyl-3,4-dihydroxyphenylalanine, and 5-S-cysteinyl-3,4-dihydroxyphenylacetic acid. J Neurochem 54(2):578\u2013586. https:\/\/doi.org\/10.1111\/j.1471-4159.1990.tb01910.x","journal-title":"J Neurochem"},{"issue":"2","key":"2718_CR33","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1111\/j.1471-4159.1990.tb04183.x","volume":"55","author":"B Fornstedt","year":"1990","unstructured":"Fornstedt B, Pileblad E, Carlsson A (1990b) In vivo autoxidation of dopamine in guinea pig striatum increases with age. J Neurochem 55(2):655\u2013659. https:\/\/doi.org\/10.1111\/j.1471-4159.1990.tb04183.x","journal-title":"J Neurochem"},{"key":"2718_CR34","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0378-4347(94)00417-4","volume":"663","author":"B FornstedtWallin","year":"1995","unstructured":"FornstedtWallin B, Bergh I (1995) A sensitive high-performance liquid chromatographic method for the determination 5-S-cysteinyldopamine, of 5-S-cysteinyl-3,4-dihydroxyphenylacetic acid and of 5-S-cysteinyl-3,4-dihydroxyphenylalanine. J Chromatogr B 663:9\u201314","journal-title":"J Chromatogr B"},{"key":"2718_CR35","doi-asserted-by":"publisher","first-page":"5999","DOI":"10.3390\/ijms22115999","volume":"22","author":"DS Goldstein","year":"2021","unstructured":"Goldstein DS (2021) The catecholaldehyde hypothesis for the pathogenesis of catecholaminergic neurodegeneration: what we know and what we do not know. Int J Mol Sci 22:5999. https:\/\/doi.org\/10.3390\/ijms22115999","journal-title":"Int J Mol Sci"},{"key":"2718_CR36","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/jnc.12345","volume":"126","author":"DS Goldstein","year":"2013","unstructured":"Goldstein DS, Sullivan P, Holmes C, Miller GW, Alter S, Strong R, Mash DC, Kopin IJ, Sharabi Y (2013) Determinants of buildup of the toxic dopamine metabolite DOPAL in Parkinson\u2019s disease. J Neurochem 126:591\u2013603","journal-title":"J Neurochem"},{"key":"2718_CR38","first-page":"644","volume":"14","author":"DG Graham","year":"1978","unstructured":"Graham DG, Tiffany S, Bell WR Jr, Gutknecht WF (1978) Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine and related compounds toward C1300 neuroblastoma cells in vitro. Mol Pharmacol 14:644\u2013653","journal-title":"Mol Pharmacol"},{"issue":"4","key":"2718_CR39","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1136\/jnnp.16.4.213","volume":"16","author":"JG Greenfeld","year":"1953","unstructured":"Greenfeld JG, Bosanquet FD (1953) The brain-stem lesions in Parkinsonism. J Neurol Neurosurg Psychiatry 16(4):213\u2013226","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2718_CR40","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/j.1600-0404.1989.tb01779.x","volume":"126","author":"B Halliwell","year":"1989","unstructured":"Halliwell B (1989) Oxidants and the central nervous system: some fundamental questions. Is oxidant damage relevant to Parkinson\u2019s disease, Alzheimer\u2019s disease, traumatic injury or stroke? Acta Neurol Scand Suppl 126:23\u201333. https:\/\/doi.org\/10.1111\/j.1600-0404.1989.tb01779.x","journal-title":"Acta Neurol Scand Suppl"},{"key":"2718_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/bj2190001","volume":"219","author":"B Halliwell","year":"1984","unstructured":"Halliwell B, Gutteridge C (1984) Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem J 219:1\u201314","journal-title":"Biochem J"},{"key":"2718_CR42","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1073\/pnas.93.5.1956","volume":"93","author":"T Hastings","year":"1996","unstructured":"Hastings T, Lewis DA, Zigmond MJ (1996) Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections. Proc Natl Acad Sci USA 93:1956\u20131961","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6180","key":"2718_CR43","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/334345a0","volume":"334","author":"EC Hirsch","year":"1988","unstructured":"Hirsch EC, Graybiel AM, Agid YA (1988) Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson\u2019s disease. Nature 334(6180):345\u2013348. https:\/\/doi.org\/10.1038\/334345a0","journal-title":"Nature"},{"key":"2718_CR44","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1600-0404.1989.tb01778.x","volume":"126","author":"EC Hirsch","year":"1989","unstructured":"Hirsch EC, Graybiel AM, Agid Y (1989) Selective vulnerability of pigmented dopaminergic neurons in Parkinson\u2019s disease. Acta Neurol Scand Suppl 126:19\u201322. https:\/\/doi.org\/10.1111\/j.1600-0404.1989.tb01778.x","journal-title":"Acta Neurol Scand Suppl"},{"key":"2718_CR45","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1111\/j.1471-4159.1991.tb08170.x","volume":"56","author":"EC Hirsch","year":"1991","unstructured":"Hirsch EC, Brandel J-P, Galle P, Javoy-Agid F, Agid Y (1991) Iron and aluminium increase in the substantia nigra of patients with Parkinson\u2019s disease: an X-ray microanalysis. J Neurochem 56:446\u2013451","journal-title":"J Neurochem"},{"key":"2718_CR46","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1007\/BF01946005","volume":"33","author":"S Ito","year":"1977","unstructured":"Ito S, Prota G (1977) A facile one-step synthesis of cysteinyldopas using mushroom tyrosinase. Experientia 33:1118\u20131119","journal-title":"Experientia"},{"key":"2718_CR47","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/S0378-4347(00)83700-7","volume":"375","author":"S Ito","year":"1986","unstructured":"Ito S, Fujita K, Yoshioka M, Sienko D, Nagatsu T (1986) Identification of 5-S- and 2-S-cysteinyldopamine and 5-S-glutathionyldopamine formed from dopamine by high-performance liquid chromatography with electrochemical detection. J Chromatogr 375:134\u2013140","journal-title":"J Chromatogr"},{"key":"2718_CR48","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1016\/0006-2952(88)90432-7","volume":"37","author":"S Ito","year":"1988","unstructured":"Ito S, Kato T, Fujita K (1988) Covalent binding of catechols to proteins through the sulphydryl group. Biochem Pharmacol 37:1707\u20131710","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"2718_CR49","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00702-022-02574-6","volume":"130","author":"S Ito","year":"2022","unstructured":"Ito S, Napolitano A, Sarna T, Wakamatsu K (2022) Iron and copper ions accelerate and modify dopamine oxidation to eumelanin: implications for neuromelanin genesis. J Neural Trans (Vienna) 130(1):29\u201342. https:\/\/doi.org\/10.1007\/s00702-022-02574-6","journal-title":"J Neural Trans (Vienna)"},{"key":"2718_CR50","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/BF02252926","volume":"2","author":"K Jellinger","year":"1990","unstructured":"Jellinger K, Paulus W, Grundke-Iqbal Riederer P, Youdim MBH (1990) Brain iron and ferritin in Parkinson\u2019s and Alzheimer\u2019s diseases. J Neural Transm [P-S Sect] 2:327\u2013340","journal-title":"J Neural Transm [P-S Sect]"},{"key":"2718_CR51","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/0304-4165(86)90034-6","volume":"881","author":"T Kato","year":"1986","unstructured":"Kato T, Ito S, Fujita K (1986) Tyrosinase-catalyzed binding of 3,4-dihydroxyphenylalanine with proteins through the sulfhydryl group. Biochim Biophys Acta 881:415\u2013421","journal-title":"Biochim Biophys Acta"},{"key":"2718_CR52","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/0304-3940(85)90078-3","volume":"58","author":"SJ Kish","year":"1985","unstructured":"Kish SJ, Morito C, Hornykiewicz O (1985) Glutathione peroxidase activity in Parkinson\u2019s disease brain. Neurosci Lett 58:343\u2013346","journal-title":"Neurosci Lett"},{"key":"2718_CR54","doi-asserted-by":"publisher","first-page":"3","DOI":"10.15586\/codonpublications.parkinsonsdisease.2018.ch1","volume-title":"Parkinson\u2019s disease: pathogenesis and clinical aspects","author":"A Kouli","year":"2018","unstructured":"Kouli A, Torsney KM, Kuan WL (2018) Parkinson\u2019s disease: etiology, neuropathology, and pathogenesis. In: Stoker TB et al (eds) Parkinson\u2019s disease: pathogenesis and clinical aspects. CODON Publications, Singapore, pp 3\u201326"},{"issue":"4","key":"2718_CR55","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.pneurobio.2011.06.005","volume":"94","author":"J Lipski","year":"2011","unstructured":"Lipski J, Nistico R, Berretta N, Guatteo E, Bernardi G, Mercuri NB (2011) L-DOPA: a scapegoat for accelerated neurodegeneration in Parkinson\u2019s disease? Prog Neurobiol 94(4):389\u2013407. https:\/\/doi.org\/10.1016\/j.pneurobio.2011.06.005","journal-title":"Prog Neurobiol"},{"key":"2718_CR56","first-page":"563","volume":"10","author":"ME Maguire","year":"1974","unstructured":"Maguire ME, Goldmann PH, Gilman AG (1974) The reaction of [3H]norepinephrine with particulate fractions of cells responsive to catecholamines. Mol Pharmacol 10:563\u2013581","journal-title":"Mol Pharmacol"},{"issue":"2","key":"2718_CR57","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0047-6374(83)90074-x","volume":"21","author":"DM Mann","year":"1983","unstructured":"Mann DM, Yates PO (1983) Possible role of neuromelanin in the pathogenesis of Parkinson\u2019s disease. Mech Ageing Dev 21(2):193\u2013203. https:\/\/doi.org\/10.1016\/0047-6374(83)90074-x","journal-title":"Mech Ageing Dev"},{"issue":"10","key":"2718_CR58","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.bbapap.2019.03.001","volume":"1867","author":"S Mehra","year":"2019","unstructured":"Mehra S, Sahay S, Maji SK (2019) \u03b1-Synuclein misfolding and aggregation: Implications in Parkinson\u2019s disease pathogenesis. Biochim Biophys Acta Proteins Proteom 1867(10):890\u2013908. https:\/\/doi.org\/10.1016\/j.bbapap.2019.03.001","journal-title":"Biochim Biophys Acta Proteins Proteom"},{"key":"2718_CR59","volume-title":"Analyses of messy data","author":"GA Milliken","year":"1984","unstructured":"Milliken GA, Johnson DE (1984) Analyses of messy data. Lifetime Learning Publications, Belmont, CA, USA"},{"issue":"20","key":"2718_CR60","doi-asserted-by":"publisher","first-page":"6512","DOI":"10.1002\/anie.201811122","volume":"58","author":"E Monzani","year":"2019","unstructured":"Monzani E, Nicolis S, Dell\u2019Acqua S, Capucciati A, Bacchella C, Zucca FA, Mosharov EV, Sulzer D, Zecca L, Casella L (2019) Dopamine, oxidative stress and protein-quinone modifcations in Parkinson\u2019s and other neurodegenerative diseases. Angew Chem Int Ed Engl 58(20):6512\u20136527","journal-title":"Angew Chem Int Ed Engl"},{"key":"2718_CR61","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.neuron.2009.01.033","volume":"62","author":"EV Mosharov","year":"2009","unstructured":"Mosharov EV et al (2009) Interplay between cytosolic dopamine, calcium, and alpha-synuclein causes selective death of substantia nigra neurons. Neuron 62:218\u2013229. https:\/\/doi.org\/10.1016\/j.neuron.2009.01.033","journal-title":"Neuron"},{"issue":"8","key":"2718_CR62","doi-asserted-by":"publisher","first-page":"4176","DOI":"10.3390\/ijms23084176","volume":"23","author":"T Nagatsu","year":"2022","unstructured":"Nagatsu T, Nakashima A, Watanabe H, Ito S, Wakamatsu K (2022) Neuromelanin in Parkinson\u2019s disease: tyrosine hydroxylase and tyrosinase. Int J Mol Sci 23(8):4176. https:\/\/doi.org\/10.3390\/ijms23084176","journal-title":"Int J Mol Sci"},{"key":"2718_CR63","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s00702-023-02617-6","volume":"130","author":"T Nagatsu","year":"2023","unstructured":"Nagatsu T, Nakashima A, Watanabe H, Ito S, Wakamatsu K, Zucca FA, Zecca L, Youdim M, Wulf M, Riederer P, Dijkstra J (2023) The role of tyrosine hydroxylase as a key player in neuromelanin synthesis and the association of neuromelanin with Parkinson\u2019s disease. J Neural Trans 130:611\u2013625. https:\/\/doi.org\/10.1007\/s00702-023-02617-6","journal-title":"J Neural Trans"},{"key":"2718_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-019-0165-9","author":"SY-Y Pang","year":"2019","unstructured":"Pang SY-Y, Ho PW, Liu HF, Leung CT, Li L, Chang EES, Ramsden DB, Ho SL (2019) The interplay of aging, genetics and environmental factors in the pathogenesis of Parkinson\u2019s disease. Transl Neurodegen. https:\/\/doi.org\/10.1186\/s40035-019-0165-9","journal-title":"Transl Neurodegen"},{"key":"2718_CR65","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/0304-3940(82)90390-1","volume":"33","author":"TL Perry","year":"1982","unstructured":"Perry TL, Goldin DV, Hansen S (1982) Parkinson\u2019s disease: a disorder due to nigral glutathione deficiency? Neurosci Lett 33:305\u2013310","journal-title":"Neurosci Lett"},{"issue":"24","key":"2718_CR66","doi-asserted-by":"publisher","first-page":"8210","DOI":"10.1523\/JNEUROSCI.5456-13.2014","volume":"34","author":"C Pifl","year":"2014","unstructured":"Pifl C, Rajput A, Reither H, Blesa J, Cavada C, Obeso JA, Rajput AH, Hornykiewicz O (2014) Is Parkinson\u2019s disease a vesicular dopamine storage disorder? Evidence from a study in isolated synaptic vesicles of human and nonhuman primate striatum. J Neurosci 34(24):8210\u20138218. https:\/\/doi.org\/10.1523\/JNEUROSCI.5456-13.2014","journal-title":"J Neurosci"},{"key":"2718_CR67","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3389\/fnins.2018.00161","volume":"12","author":"MR Post","year":"2018","unstructured":"Post MR, Lieberman OJ, Mosharov EV (2018) Can interactions between \u03b1-synuclein, dopamine and calcium explain selective neurodegeneration in Parkinson\u2019s disease? Front Neurosci 12:161. https:\/\/doi.org\/10.3389\/fnins.2018.00161","journal-title":"Front Neurosci"},{"issue":"2","key":"2718_CR68","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/j.1471-4159.1989.tb09150.x","volume":"52","author":"P Riederer","year":"1989","unstructured":"Riederer P, Sofc E, Rausch WD, Schmidt B, Reynolds GP, Jellinger K, Youdim MB (1989) Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. J Neurochem 52(2):515\u2013520. https:\/\/doi.org\/10.1111\/j.1471-4159.1989.tb09150.x","journal-title":"J Neurochem"},{"issue":"7","key":"2718_CR69","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1007\/s00702-019-02025-9","volume":"126","author":"P Riederer","year":"2019","unstructured":"Riederer P, Berg D, Casadei N, Cheng F, Classen J, Dresel C et al (2019) \u03b1-Synuclein in Parkinson\u2019s disease: causal or bystander? J Neural Transm 126(7):815\u2013840. https:\/\/doi.org\/10.1007\/s00702-019-02025-9","journal-title":"J Neural Transm"},{"issue":"10","key":"2718_CR70","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1007\/s00702-021-02414-z","volume":"128","author":"P Riederer","year":"2021","unstructured":"Riederer P, Monoranu C, Strobel S, Iordache T, Sian-H\u00fclsmann J (2021) Iron as the concert master in the pathogenic orchestra playing in sporadic Parkinson\u2019s disease. J Neural Transm (Vienna) 128(10):1577\u20131598. https:\/\/doi.org\/10.1007\/s00702-021-02414-z","journal-title":"J Neural Transm (Vienna)"},{"key":"2718_CR71","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s00702-023-02630-9","volume":"130","author":"P Riederer","year":"2023","unstructured":"Riederer P, Nagatsu T, Youdim MBH, Wulf M, Dijkstra JM, Sian-Huelsmann J (2023) Lewy bodies, iron, inflammation and neuromelanin: pathological aspects underlying Parkinson\u2019s disease. J Neural Trans 130:627\u2013646. https:\/\/doi.org\/10.1007\/s00702-023-02630-9","journal-title":"J Neural Trans"},{"key":"2718_CR72","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/BF01252029","volume":"63","author":"E Rosengren","year":"1985","unstructured":"Rosengren E, Linder-Eliasson E, Carlsson A (1985) Detection of 5-S-cysteinyl-DA in human brain. J Neural Transm 63:247\u2013253","journal-title":"J Neural Transm"},{"key":"2718_CR73","first-page":"352","volume":"94","author":"H Saggu","year":"1988","unstructured":"Saggu H, Cooksey J, Dexter D, Jenner P, Marsden CD (1988) A selective increase in mitochondrial superoxide dismutase in parkinsonian substantia nigra. Br J Pharmacol 94:352","journal-title":"Br J Pharmacol"},{"key":"2718_CR75","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1016\/0006-291X(75)90514-8","volume":"66","author":"V Scheulen","year":"1975","unstructured":"Scheulen V, Wollenberg P, Bolt H, Kappus H, Remmer H (1975) Irreversible binding of dopa and dopamine metabolites to protein by rat liver microsomes. Biochem Biophys Res Commun 66:1396\u20131400","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"2718_CR76","first-page":"143","volume":"3","author":"SD Segura-Aguilar","year":"2019","unstructured":"Segura-Aguilar SD, Zucca FA, Zecca L (2019) Overexpression of vesicular monoamine transporter-2 may block neurotoxic metabolites from cytosolic dopamine: a potential neuroprotective therapy for Parkinson\u2019s disease. Clin Pharmacol Transl Med 3(1):143\u2013148","journal-title":"Clin Pharmacol Transl Med"},{"issue":"7","key":"2718_CR77","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1021\/tx980036t","volume":"11","author":"XM Shen","year":"1998","unstructured":"Shen XM, Dryhurst G (1998) Iron-and manganese-catalyzed autooxidation of dopamine in the presence of L-cysteine: possible insights into iron- and manganese-mediated dopaminergic neurotoxicity. Chem Res Toxicol 11(7):824\u2013837. https:\/\/doi.org\/10.1021\/tx980036t","journal-title":"Chem Res Toxicol"},{"key":"2718_CR78","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/BF01244786","volume":"74","author":"E Sofic","year":"1988","unstructured":"Sofic E, Riederer P, Heinsen H, Beckmann H, Reynolds GP, Hebenstreit G, Youdim MBH (1988) Increased iron (III) and total iron content in post mortem subsstantia nigra of parkinsonian brain. J Neural Transm 74:199\u2013205","journal-title":"J Neural Transm"},{"key":"2718_CR79","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1111\/j.1471-4159.1991.tb02017.x","volume":"56","author":"E Sofic","year":"1991","unstructured":"Sofic E, Paulus W, Jellinger K, Riderer P, Youdim MBH (1991) Selective increase of iron in substantia nigra zona compacta of parkinsonian brains. J Neurochem 56:978\u2013982","journal-title":"J Neurochem"},{"key":"2718_CR80","first-page":"261","volume":"LXXVII","author":"H Spatz","year":"1922","unstructured":"Spatz H (1922) \u00dcber den eisennachweis in gehrin, besonders in zentern des extrapyramidalmotorischen systems. Z Psych LXXVII:261\u2013390","journal-title":"Z Psych"},{"issue":"5","key":"2718_CR81","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1046\/j.1471-4159.1998.71052112.x","volume":"71","author":"JP Spencer","year":"1998","unstructured":"Spencer JP, Jenner P, Daniel SE, Lees AJ, Marsden DC, Halliwell B (1998) Conjugates of catecholamines with cysteine and GSH in Parkinson\u2019s disease: possible mechanisms of formation involving reactive oxygen species. J Neurochem 71(5):2112\u20132122. https:\/\/doi.org\/10.1046\/j.1471-4159.1998.71052112.x","journal-title":"J Neurochem"},{"key":"2718_CR82","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M (1997) \u03b1-Synuclein in Lewy bodies. Nature 388:839\u2013840","journal-title":"Nature"},{"key":"2718_CR83","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.neuropharm.2012.11.010","volume":"67","author":"BJ Stansley","year":"2013","unstructured":"Stansley BJ, Yamamoto BK (2013) L-dopa-induced dopamine synthesis and oxidative stress in serotonergic cells. Neuropharmacology 67:243\u2013251. https:\/\/doi.org\/10.1016\/j.neuropharm.2012.11.010","journal-title":"Neuropharmacology"},{"issue":"22","key":"2718_CR84","doi-asserted-by":"publisher","first-page":"11869","DOI":"10.1073\/pnas.97.22.11869","volume":"97","author":"D Sulzer","year":"2000","unstructured":"Sulzer D, Bogulavsky J, Larsen KE, Behr G, Karatekin E, Kleinman MH, Turro N, Krantz D, Edwards RH, Greene LA, Zecca L (2000) Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles. Proc Natl Acad Sci USA 97(22):11869\u201311874","journal-title":"Proc Natl Acad Sci USA"},{"key":"2718_CR85","doi-asserted-by":"publisher","first-page":"859","DOI":"10.3389\/fnins.2018.00859","volume":"12","author":"Y Sun","year":"2018","unstructured":"Sun Y, Pham AN, Hare DJ, Waite TD (2018) Kinetic modeling of pH dependent oxidation of dopamine by iron and its relevance to Parkinson\u2019s disease. Front Neurosci 12:859","journal-title":"Front Neurosci"},{"issue":"6","key":"2718_CR86","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13031","volume":"18","author":"BG Trist","year":"2019","unstructured":"Trist BG, Hare DJ, Double KL (2019) Oxidative stress in the aging substantia nigra and the etiology of Parkinson\u2019s disease. Aging Cell 18(6):e13031. https:\/\/doi.org\/10.1111\/acel.13031","journal-title":"Aging Cell"},{"key":"2718_CR87","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1046\/j.1471-4159.2003.01917.x","volume":"86","author":"K Wakamatsu","year":"2003","unstructured":"Wakamatsu K, Fujikawa K, Zucca FA, Zecca L, Ito S (2003) The structure of neuromelanin as studied by chemical degradative methods. J Neurochem 86:1015\u20131023","journal-title":"J Neurochem"},{"key":"2718_CR88","doi-asserted-by":"publisher","first-page":"8039","DOI":"10.3390\/molecules19068039","volume":"19","author":"K Wakamatsu","year":"2014","unstructured":"Wakamatsu K, Tanaka H, Tabuchi K, Ojika M, Zucca FA, Zecca L, Ito S (2014) Reduction of the nitro group to amine by hydroiodic acid to synthesize o-aminophenol derivatives as putative degradative markers of neuromelanin. Molecules 19:8039\u20138050","journal-title":"Molecules"},{"issue":"4","key":"2718_CR89","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1111\/jnc.13237","volume":"135","author":"K Wakamatsu","year":"2015","unstructured":"Wakamatsu K, Tabuchi K, Ojika M, Zucca FA, Zecca L, Shosuke Ito S (2015) Norepinephrine and its metabolites are involved in the synthesis of neuromelanin derived from the locus coeruleus. J Neurochem 135(4):768\u2013776. https:\/\/doi.org\/10.1111\/jnc.13237. (PMCID: PMC5014224 PMID: 26156066)","journal-title":"J Neurochem"},{"key":"2718_CR90","doi-asserted-by":"publisher","first-page":"9163040","DOI":"10.1155\/2018\/9163040","volume":"2018","author":"M Weng","year":"2018","unstructured":"Weng M, Xie X, Liu C, Lim K-L, Zhang C-W, Li L (2018) The sources of reactive oxygen species and its possible role in the pathogenesis of Parkinson\u2019s disease. Rev Parkinsons Dis 2018:9163040. https:\/\/doi.org\/10.1155\/2018\/9163040. (eCollection 2018)","journal-title":"Rev Parkinsons Dis"},{"key":"2718_CR91","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/1523-1747.ep12546959.1","volume":"71","author":"MM Wick","year":"1978","unstructured":"Wick MM (1978) Dopamine: a novel antitumour agent active against B-16 melanoma in vivo. J Invest Deramatol 71:163\u2013164","journal-title":"J Invest Deramatol"},{"issue":"10","key":"2718_CR93","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1007\/s00702-022-02530-4","volume":"129","author":"M Wulf","year":"2022","unstructured":"Wulf M, Barkovits K, Schork K, Eisenacher K, Riederer P, Gerlach M, Eggers B, Marcus K (2022) Neuromelanin granules of the substantia nigra: proteomic profile provides links to tyrosine hydroxylase, stress granules and lysosomes. J Neural Transm 129(10):1257\u20131270. https:\/\/doi.org\/10.1007\/s00702-022-02530-4","journal-title":"J Neural Transm"},{"key":"2718_CR94","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/S0014-5793(01)03269-0","volume":"510","author":"L Zecca","year":"2002","unstructured":"Zecca L, Fariello R, Riederer P, Sulzer D, Gatti A, Tampellini D (2002) The absolute concentration of nigral neuromelanin, assayed by a new sensitive method, increases throughout the life and is dramatically decreased in Parkinson\u2019s disease. FEBS Lett 510:216\u2013220","journal-title":"FEBS Lett"},{"issue":"26","key":"2718_CR95","doi-asserted-by":"publisher","first-page":"9843","DOI":"10.1073\/pnas.0403495101","volume":"101","author":"L Zecca","year":"2004","unstructured":"Zecca L, Stroppolo A, Gatti A, Tampellini D, Toscani M, Gallorini M, Giaveri G, Arosio P, Santambrogio P, Fariello RG, Karatekin E, Kleinman MH, Turro N, Hornykiewicz O, Zucca FA (2004) The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging. Proc Natl Acad Sci USA 101(26):9843\u20139848. https:\/\/doi.org\/10.1073\/pnas.0403495101","journal-title":"Proc Natl Acad Sci USA"},{"issue":"45","key":"2718_CR96","doi-asserted-by":"publisher","first-page":"17567","DOI":"10.1073\/pnas.0808768105","volume":"105","author":"L Zecca","year":"2008","unstructured":"Zecca L, Bellei C, Costi P, Albertini A, Monzani E, Casella L, Gallorini M, Bergamaschi L, Moscatelli A, Turro NJ, Eisner M, Crippa PR, Ito S, Wakamatsu K, Bush WD, Ward WC, Simon JD, Zucca FA (2008) New melanic pigments in the human brain that accumulate in aging and block environmental toxic metals. Proc Natl Acad Sci USA 105(45):17567\u201317572. https:\/\/doi.org\/10.1073\/pnas.0808768105","journal-title":"Proc Natl Acad Sci USA"},{"key":"2718_CR97","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.pneurobio.2015.09.012","volume":"155","author":"FA Zucca","year":"2017","unstructured":"Zucca FA, Segura-Aguilar J, Ferrari E, Mu\u00f1oz P, Paris I, Sulzer D, Sarna T, Casella L, Zecca L (2017) Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson\u2019s disease. Prog Neurobiol 155:96\u2013119","journal-title":"Prog Neurobiol"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-023-02718-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00702-023-02718-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-023-02718-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T14:12:47Z","timestamp":1708179167000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00702-023-02718-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,18]]},"references-count":92,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["2718"],"URL":"https:\/\/doi.org\/10.1007\/s00702-023-02718-2","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,18]]},"assertion":[{"value":"14 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author has no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the appropriate institutional and\/or national research ethics committee and the study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}